Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Belen Rubio Morell & Sergio Hernández Expósito. (2019) Differential long-term medication impact on executive function and delay aversion in ADHD. Applied Neuropsychology: Child 8:2, pages 140-157.
Read now
Read now
Joshua Caballero, Edress H Darsey, Faith Walters & Heidi W Belden. (2017) Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists. Integrated Pharmacy Research and Practice 6, pages 163-171.
Read now
Read now
Articles from other publishers (20)
Amy J. Lynham, Sarah Knott, Jack F. G. Underwood, Leon Hubbard, Sharifah S. Agha, Jonathan I. Bisson, Marianne B. M. van den Bree, Samuel J. R. A. Chawner, Nicholas Craddock, Michael O'Donovan, Ian R. Jones, George Kirov, Kate Langley, Joanna Martin, Frances Rice, Neil P. Roberts, Anita Thapar, Richard Anney, Michael J. Owen, Jeremy Hall, Antonio F. Pardiñas & James T. R. Walters. (2023) DRAGON-Data: a platform and protocol for integrating genomic and phenotypic data across large psychiatric cohorts. BJPsych Open 9:2.
Crossref
Crossref
Bruna Santos da Silva, Eugenio Horacio Grevet, Luiza Carolina Fagundes Silva, João Kleber Neves Ramos, Diego Luiz Rovaris & Claiton Henrique Dotto Bau. (2023) An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder. Discover Mental Health 3:1.
Crossref
Crossref
Jie Ding, Yiyun Ding, Jingjing Wu, Jialin Deng, Qingyang Yu & Junhong Wang. (2022) “Jing-Ning Granules” Can Alleviate Attention Deficit Hyperactivity Disorder in Rats by Modulating Dopaminergic D2/D1-Like Receptor-Mediated Signaling Pathways. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-15.
Crossref
Crossref
Sofia Pinto, Teresa Correia-de-Sá, Benedita Sampaio-Maia, Carla Vasconcelos, Pedro Moreira & Joana Ferreira-Gomes. (2022) Eating Patterns and Dietary Interventions in ADHD: A Narrative Review. Nutrients 14:20, pages 4332.
Crossref
Crossref
Fatma Gamal, Osama El Agami & Abeer Salamah. (2022) Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorder
in Children: A Randomized Controlled Trial. CNS & Neurological Disorders - Drug Targets 21:8, pages 717-723.
Crossref
Crossref
Jeremy E Solly, Jon E Grant & Samuel R Chamberlain. (2022) Pharmacological interventions for Problematic Usage of the Internet (PUI): a narrative review of current progress and future directions. Current Opinion in Behavioral Sciences 46, pages 101158.
Crossref
Crossref
Allan I Levey, Deqiang Qiu, Liping Zhao, William T Hu, Duc M Duong, Lenora Higginbotham, Eric B Dammer, Nicholas T Seyfried, Thomas S Wingo, Chadwick M Hales, Malú Gámez Tansey, David S Goldstein, Anees Abrol, Vince D Calhoun, Felicia C Goldstein, Ihab Hajjar, Anne M Fagan, Doug Galasko, Steven D Edland, John Hanfelt, James J Lah & David Weinshenker. (2022) A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain 145:6, pages 1924-1938.
Crossref
Crossref
Wendy Verónica Herrera-Morales, Leticia Ramírez-Lugo, Roger Cauich-Kumul, Eric Murillo-Rodríguez & Luis Núñez-Jaramillo. (2022) Personalization of Pharmacological Treatments for ADHD: Why it is
Advisable and Possible Options to Achieve it. Current Topics in Medicinal Chemistry 22:15, pages 1236-1249.
Crossref
Crossref
Meghna Rajaprakash & Mary L. Leppert. (2022) Attention-Deficit/Hyperactivity Disorder. Pediatrics In Review 43:3, pages 135-147.
Crossref
Crossref
Di Fu, Dan-Dan Wu, Hong-Li Guo, Ya-Hui Hu, Ying Xia, Xing Ji, Wei-Rong Fang, Yun-Man Li, Jing Xu, Feng Chen & Qian-Qi Liu. (2022) The Mechanism, Clinical Efficacy, Safety, and Dosage Regimen of Atomoxetine for ADHD Therapy in Children: A Narrative Review. Frontiers in Psychiatry 12.
Crossref
Crossref
Ying Xia, Hong-Li Guo, Ya-Hui Hu, Jia-Yi Long, Jing Chen, Feng Chen & Xing Ji. (2021) Determination of atomoxetine levels in human plasma using LC-MS/MS and clinical application to Chinese children with ADHD based on CPIC guidelines. Analytical Methods 13:21, pages 2434-2441.
Crossref
Crossref
Luis Núñez-Jaramillo, Andrea Herrera-Solís & Wendy Verónica Herrera-Morales. (2021) ADHD: Reviewing the Causes and Evaluating Solutions. Journal of Personalized Medicine 11:3, pages 166.
Crossref
Crossref
Gurmukh Singh, Priti Arun, Subhash Das & Damanjeet Kaur. (2019) Can EEG Predict Response to Atomoxetine in attention deficit hyperactivity disorder at 1 Week?. Journal of Attention Disorders 25:5, pages 758-767.
Crossref
Crossref
Prateek Yadav. 2021. New Developments in Diagnosing, Assessing, and Treating ADHD. New Developments in Diagnosing, Assessing, and Treating ADHD
132
145
.
Daniela Zmeškalová. (2020) Atomoxetine. Psychiatrie pro praxi 21:1, pages 47-52.
Crossref
Crossref
Joy A. Weydert, Melanie L. Brown & Hilary McClafferty. (2018) Integrative Medicine in Pediatrics. Advances in Pediatrics 65:1, pages 19-39.
Crossref
Crossref
Carlin J. Miller. 2018. Encyclopedia of Adolescence. Encyclopedia of Adolescence
319
336
.
Tian Lan, Xiao-Xia Hu, Bing-Qing Liang, Wen-He Pan, Quan Zhou, Ling-Jing Yuan & Guo-Xin Hu. (2016) The Effect of Myricetin on Pharmacokinetics of Atomoxetine and its Metabolite 4-Hydroxyatomoxetine In Vivo and In Vitro. European Journal of Drug Metabolism and Pharmacokinetics 42:2, pages 261-268.
Crossref
Crossref
Kanchan Sharma, Thomas Davis & Elizabeth Coulthard. (2016) Enhancing attention in neurodegenerative diseases: current therapies and future directions. Translational Neuroscience 7:1, pages 98-109.
Crossref
Crossref
Carlin J. Miller. 2016. Encyclopedia of Adolescence. Encyclopedia of Adolescence
1
18
.